THERAPEUTIC EFFECTS
A random selection of therapeutic effects appears here in context of their evidence status. Some of the effects will be shown as beneficial, while others carry risk. Some effects are barely distinguished from the placebos of the research.
Cannabis in the treatment of epilepsy is inconclusive on account of insufficient evidence.
Nausea and vomiting caused by chemotherapy can be ameliorated by oral cannabis.
A reduction in the severity of pain in patients with chronic pain is a likely outcome for the use of cannabis.
Spasticity in Multiple Sclerosis (MS) patients was reported as improvements in symptoms.
Increase in appetite and decrease in weight loss in HIV/ADS patients has been shown in limited evidence.
According to limited evidence cannabis is ineffective in the treatment of glaucoma.
On the basis of limited evidence, cannabis is effective in the treatment of Tourette syndrome.
Post-traumatic disorder has been helped by cannabis in a single reported trial.
Limited statistical evidence points to better outcomes for traumatic brain injury.
There is insufficient evidence to claim that cannabis can help Parkinson's disease - buy real weed online.
Limited evidence dashed hopes that cannabis could help improve the symptoms of dementia sufferers.
Limited statistical evidence can be found to support an association between smoking cannabis and heart attack.
On the basis of limited evidence cannabis is ineffective to treat depression
The evidence for reduced risk of metabolic issues (diabetes etc) is limited and statistical.
Social anxiety disorders can be helped by cannabis, although the evidence is limited. Asthma and cannabis use is not well supported by the evidence either for or against.
Post-traumatic disorder has been helped by cannabis in a single reported trial.
A conclusion that cannabis can help schizophrenia sufferers cannot be supported or refuted on the basis of the limited nature of the evidence.
There is moderate evidence that better short-term sleep outcomes for disturbed sleep individuals.
Pregnancy and smoking cannabis are correlated with reduced birth weight of the infant.
The evidence for stroke caused by cannabis use is limited and statistical.
Addiction to cannabis and gateway issues are complex, taking into account many variables that are beyond the scope of this article. These issues are fully discussed in the NAP report.
A random selection of therapeutic effects appears here in context of their evidence status. Some of the effects will be shown as beneficial, while others carry risk. Some effects are barely distinguished from the placebos of the research.
Cannabis in the treatment of epilepsy is inconclusive on account of insufficient evidence.
Nausea and vomiting caused by chemotherapy can be ameliorated by oral cannabis.
A reduction in the severity of pain in patients with chronic pain is a likely outcome for the use of cannabis.
Spasticity in Multiple Sclerosis (MS) patients was reported as improvements in symptoms.
Increase in appetite and decrease in weight loss in HIV/ADS patients has been shown in limited evidence.
According to limited evidence cannabis is ineffective in the treatment of glaucoma.
On the basis of limited evidence, cannabis is effective in the treatment of Tourette syndrome.
Post-traumatic disorder has been helped by cannabis in a single reported trial.
Limited statistical evidence points to better outcomes for traumatic brain injury.
There is insufficient evidence to claim that cannabis can help Parkinson's disease - buy real weed online.
Limited evidence dashed hopes that cannabis could help improve the symptoms of dementia sufferers.
Limited statistical evidence can be found to support an association between smoking cannabis and heart attack.
On the basis of limited evidence cannabis is ineffective to treat depression
The evidence for reduced risk of metabolic issues (diabetes etc) is limited and statistical.
Social anxiety disorders can be helped by cannabis, although the evidence is limited. Asthma and cannabis use is not well supported by the evidence either for or against.
Post-traumatic disorder has been helped by cannabis in a single reported trial.
A conclusion that cannabis can help schizophrenia sufferers cannot be supported or refuted on the basis of the limited nature of the evidence.
There is moderate evidence that better short-term sleep outcomes for disturbed sleep individuals.
Pregnancy and smoking cannabis are correlated with reduced birth weight of the infant.
The evidence for stroke caused by cannabis use is limited and statistical.
Addiction to cannabis and gateway issues are complex, taking into account many variables that are beyond the scope of this article. These issues are fully discussed in the NAP report.
Comments
Post a Comment